Who are CTRL Therapeutics's investors?

CTRL Therapeutics's investors include General Catalyst, Portal Innovations.

When was CTRL Therapeutics founded?

CTRL Therapeutics was founded in 2023.

Where is CTRL Therapeutics headquartered?

CTRL Therapeutics is headquartered in Chicago, Illinois, United States.

What industry is CTRL Therapeutics in?

CTRL Therapeutics operates in Life Sciences, Biotech, Healthcare.

How many employees does CTRL Therapeutics have?

CTRL Therapeutics has 11-50 employees.

CTRL Therapeutics

Chicago, United States · Founded 2023

Life Sciences

Biotech

Healthcare

Headquarters: Chicago, Illinois
Employees: 11–50
Founded: 2023
Business Model: B2B

Website: ctrl-therapeutics.com
Last Round: Series ASep 2024
Rounds: 2

About

CTRL Therapeutics is developing a first-of-its-kind polyclonal cell therapy platform to treat solid tumors using circulating tumor-reactive lymphocytes (cTRLs) isolated from blood rather than tumor tissue. The company's proprietary IsoQore™ cell-sorting platform enables efficient extraction of millions of cTRLs through a simple blood draw, avoiding invasive surgical procedures required by traditional TIL therapies. CTRL's lead product, cTRL-001, aims to provide a scalable, outpatient-ready solution for a broad range of solid tumors.

Summary

CTRL Therapeutics is a Life Sciences company based in Chicago, United States, founded in 2023. Its most recent funding was a Series A round in Sep 2024. Investors include General Catalyst and Portal Innovations.